Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
about
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationPre-referral rectal artesunate for severe malariaPre-referral rectal artesunate for severe malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaPopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesPopulation pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New GuineaArtemisinins.Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria.Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New GuineaOpposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.Towards optimal design of anti-malarial pharmacokinetic studies.The evolution of metabolic profiling in parasitology.The pharmacokinetic evaluation of artemisinin drugs for the treatment of malaria in paediatric populations.The pharmacogenetics of antimalaria artemisinin combination therapy.Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.
P2860
Q21034080-927B36E5-2912-4444-8D90-EEFD11B37BF1Q24194527-2DD88357-D192-4DB3-AC82-AEADD03E2B3CQ24202504-A40247C6-D920-46D3-AF7B-B4785EEA5AB2Q24235351-1AA365D8-59F3-4E93-A79E-386E79C707F0Q28469076-E22C68FA-7090-4E05-983F-9E40472ED966Q28481649-4C94B15B-7E84-464F-B72A-296451E86778Q28535686-CFB6CE11-ED7B-4D68-B9F9-B4E10BB897E2Q30867699-972989D2-0B42-4645-997E-44ACCF6C3C19Q31150958-E000B821-D6D4-41FC-AB05-AEF6D1DDE770Q33590189-3C9E5815-94C8-4FE6-A1A1-688244B5B893Q34509744-35AAA804-F2B2-4399-B740-456010D69891Q35521094-E447EB63-5FEC-4E1C-AAB5-EF45EC529F4DQ35607695-620DC8A4-C4BB-4FEC-B117-173AA17ADC4BQ35669950-F9786EB9-C574-405C-A533-B5E724615E79Q36125445-5A050979-1C58-4189-8CC4-E7A5D3CAD64EQ36778732-FBBE56C1-ECAF-434A-8ABD-2CD51CAC81CDQ36959519-1EE724F1-E4A8-47B0-BF41-1BD8AAEFE478Q37320525-EF575639-2D6D-4A38-A09B-C4238738E095Q37742204-701D4FC4-D262-4CD7-BBB0-703417A11096Q37841602-B8E83545-ACA4-4BFD-BF7B-C20406AC1577Q37928680-B22B0466-31C3-4822-AD8B-4D65FD7A1D6FQ39468706-3DAD9995-60BE-4136-9919-6DEC2776AF07
P2860
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Disposition of artesunate and ...... ea with uncomplicated malaria.
@ast
Disposition of artesunate and ...... ea with uncomplicated malaria.
@en
type
label
Disposition of artesunate and ...... ea with uncomplicated malaria.
@ast
Disposition of artesunate and ...... ea with uncomplicated malaria.
@en
prefLabel
Disposition of artesunate and ...... ea with uncomplicated malaria.
@ast
Disposition of artesunate and ...... ea with uncomplicated malaria.
@en
P2093
P2860
P1476
Disposition of artesunate and ...... ea with uncomplicated malaria.
@en
P2093
Adedayo Kemiki
Harin A Karunajeewa
Kenneth F Ilett
Kitiya Dufall
Michael P Alpers
Moses Bockarie
P Hugh Barrett
Paolo Vicini
Timothy M E Davis
P2860
P304
P356
10.1128/AAC.48.8.2966-2972.2004
P407
P577
2004-08-01T00:00:00Z